Samyang Holdings Biopharm

South Korea-based Samyang Holdings Biopharm Group has secured a partnership with Hangzhou-based Yxintent, a specialist in medical devices and aesthetics, for its dermal filler product Lafullen. The partnership deal grants Yxintent the development and commercialization rights to Lafullen in China, marking a significant step for Samyang as it expands into…